A consequence of progressive liver disease and generalized CD8+ T-cell dysfunction may result in insufficient responses to other concurrent infections, negatively influence vaccine immunogenicity (e.g. influenza, HBV) or contribute to the risk for hepatocellular carcinoma. Here, CD8A is linked to liver disorder.